FDA Seeks Patient Input
On August 25, the Food and Drug Administration (FDA) will host a Patient-Focused Drug Development meeting on nonhealing chronic wounds. The purpose of the meeting is to help FDA and other stakeholders better understand the patient experience, including how chronic wounds affect daily life, challenges with current treatments, and factors that influence participation in clinical trials.
Read More
APMA Opposes Federal Funding Restrictions
APMA joined over 150 physician, research, and healthcare-related organizations in support of a letter, led by the International Association of Scientific, Technical & Medical Publishers, urging congressional leaders on the House and Senate Appropriations Committees to reject proposed regulations in the FY 2027 Presidential Budget Request that would restrict federal grant funding to scientific publications.
Read More
APMA Meeting With Aetna
APMA recently met with Aetna leadership as part of APMA’s ongoing quarterly discussions with the insurer. Topics included prior authorization modernization, provider experience issues, modifier 25 concerns, and the use of AI and digital tools to streamline administrative processes.
Read More
New Walk the District 2026 Resource Page
To help strengthen local advocacy and build relationships between Congress and our profession, APMA is encouraging members to “Walk the District” and meet with federal lawmakers in their states during this year’s Congressional Recess, from August 10–28.
Read More
Gold Carding Exemptions in Texas
APMA recently received a positive update regarding implementation of the CMS Wasteful and Inappropriate Services Reduction (WISeR) Model. Cohere Health, the model participant administering WISeR in Texas, has begun notifying providers who qualify for its new "gold carding" program.
Read More
Prior Authorization Reform Bill
One of APMA’s key legislative priorities, the Seniors’ Act, has reached 290 cosponsors in the House of Representatives. The bicameral, bipartisan bill, led by Represenatives Mike Kelly (R-PA) and Suzan DelBene (D-WA), would establish an electronic prior authorization (PA) process in Medicare Advantage (MA) to streamline coverage decisions for medically necessary care.
Read More
Prior Authorization for Electronic Prescriptions and DMEPOS
APMA responded to the CMS proposed rule on interoperability standards and prior authorization for prescription drugs, which also included two requests for information related to health-care cybersecurity and durable medical equipment prosthetics and supplies (DMEPOS) prior authorization. APMA’s recommendations reflect APMA's ongoing commitment to reducing administrative burdens on physicians while ensuring timely patient access to medically necessary care.
Read More
Florida Law Preserves Podiatrists’ Access to CTP
APMA congratulates the Florida Podiatric Medical Association (FPMA) on the enactment of legislation, SB 1092, that preserves podiatric physicians’ ability to utilize certain cellular or tissue-based products (including skin substitutes) not approved by the Food and Drug Administration (FDA) within their scope of practice.
Read More
Medicare Coverage Determination Process
APMA sent a letter of support to congressional champions for key legislation that would strengthen transparency, stakeholder engagement, and consistency within the Medicare local coverage determination (LCD) process.
Read More
AMA House of Delegates
APMA President Patrick DeHeer, DPM, recently participated in the American Medical Association (AMA) House of Delegates, where APMA is an official observer. The meeting brings together physician leaders from specialty societies, state medical associations, and national medical organizations to discuss and shape policy on issues affecting patients and the medical profession.
Read More
Medicare Physician Payment
APMA submitted a letter to the House Energy and Commerce Health Subcommittee in response to a hearing examining the Medicare Physician Fee Schedule, the Medicare Access and CHIP Reauthorization Act (MACRA) reauthorization, and opportunities for payment reforms. APMA highlighted the importance of advancing federal reforms that tie yearly Medicare physician payment fluctuations to the Medicare Economic Index (MEI) and establish a more physician-centered Merit-Based Incentives Payment System (MIPS) framework.
Read More